Atlas Trials

REGENXBIO Inc.

18 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch REGENXBIO Inc.

RecordFirmDate
RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome) (NCT07236606)REGENXBIO Inc.2025-11-25
Long Term Follow-up for RGX-202 (NCT06491927)REGENXBIO Inc.2024-05-08
Long Term Follow-Up for RGX-111 (NCT06103487)REGENXBIO Inc.2023-07-24
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD) (NCT05693142)REGENXBIO Inc.2023-01-04
AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD (NCT05683379)REGENXBIO Inc.2022-12-20
An Observational Study in Children With CLN2 Batten Disease (NCT04462692)REGENXBIO Inc.2021-03-31
A Retrospective, Natural History Study in Children With CLN2 (NCT04480476)REGENXBIO Inc.2021-03-31
Long-term Follow-Up for RGX-121 (NCT04597385)REGENXBIO Inc.2021-03-14
RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome) (NCT04571970)REGENXBIO Inc.2021-03-11
Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients (NCT04148001)REGENXBIO Inc.2019-12-04
A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-501 (NCT04080050)REGENXBIO Inc.2019-09-30
RGX-111 Gene Therapy in Patients With MPS I (NCT03580083)REGENXBIO Inc.2019-04-03
CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome) (NCT03566043)REGENXBIO Inc.2018-09-27
Mucopolysaccharidosis Type II Natural History (NCT03529786)REGENXBIO Inc.2017-09-27

Track REGENXBIO Inc. automatically

Every clearance here is in the API, with alerts when new ones post.